Loading...
XKRX119610
Market cap211mUSD
Apr 05, Last price  
24,900.00KRW
Name

Interojo Co Ltd

Chart & Performance

D1W1MN
XKRX:119610 chart
P/E
22.50
P/S
2.55
EPS
1,106.56
Div Yield, %
2.41%
Shrs. gr., 5y
1.09%
Rev. gr., 5y
8.93%
Revenues
121.84b
-4.01%
30,074,386,31859,557,723,90473,713,983,05980,618,215,49279,428,150,52292,568,560,43488,202,799,529116,817,301,625126,927,638,910121,842,779,445
Net income
13.80b
-25.99%
8,659,143,97512,593,351,33519,347,511,80919,274,417,55514,598,097,00917,555,492,13311,543,039,25014,744,431,00018,643,576,69013,797,842,450
CFO
8.34b
-30.76%
4,826,706,12717,050,682,54615,109,267,59211,291,268,3158,761,826,77323,527,892,16416,670,750,88613,564,672,35712,047,256,0918,341,801,373
Dividend
Dec 27, 2023600 KRW/sh
Earnings
Feb 12, 2025

Profile

Interojo Inc. manufactures and sells contact lenses in South Korea and internationally. It offers silicone hydrogel lens, premium hydrogel lens, hydrogel lens, color lens, RGP, and other products. The company was founded in 2000 and is headquartered in Pyeongtaek-si, South Korea.
URL
https://www.interojo.com/
IPO date
Jul 28, 2010
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
121,842,779
-4.01%
126,927,639
8.65%
Cost of revenue
91,546,455
85,736,689
Unusual Expense (Income)
NOPBT
30,296,324
41,190,950
NOPBT Margin
24.87%
32.45%
Operating Taxes
2,439,288
4,393,526
Tax Rate
8.05%
10.67%
NOPAT
27,857,036
36,797,423
Net income
13,797,842
-25.99%
18,643,577
26.44%
Dividends
(7,478,882)
(5,609,954)
Dividend yield
1.89%
1.53%
Proceeds from repurchase of equity
(3,816,383)
(6,939,176)
BB yield
0.97%
1.90%
Debt
Debt current
47,957,748
41,278,205
Long-term debt
11,185,001
4,462,864
Deferred revenue
Other long-term liabilities
1,857,869
973,336
Net debt
14,438,396
4,875,432
Cash flow
Cash from operating activities
8,341,801
12,047,256
CAPEX
(8,270,656)
(17,307,614)
Cash from investing activities
(11,613,309)
(28,672,675)
Cash from financing activities
6,848,471
7,891,993
FCF
29,409,503
5,105,012
Balance
Cash
34,069,530
24,014,624
Long term investments
10,634,823
16,851,014
Excess cash
38,612,214
34,519,255
Stockholders' equity
159,398,292
166,507,216
Invested Capital
208,882,368
197,394,689
ROIC
13.71%
20.65%
ROCE
12.24%
17.76%
EV
Common stock shares outstanding
12,504
12,971
Price
31,600.00
12.06%
28,200.00
2.92%
Market cap
395,122,671
8.02%
365,782,679
3.69%
EV
409,553,314
370,662,641
EBITDA
40,012,223
50,441,289
EV/EBITDA
10.24
7.35
Interest
2,841,670
1,248,509
Interest/NOPBT
9.38%
3.03%